Evidence map›Paper›PMID 28267784›Full record

ArticlePLoS genetics2017

Mutations in mitochondrial DNA causing tubulointerstitial kidney disease.

Thomas M Connor, Simon Hoer, Andrew Mallett, Daniel P Gale, Aurora Gomez-Duran, Viktor Posse, Robin Antrobus, Pablo Moreno, Marco Sciacovelli, Christian Frezza and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Tissue-specific mitochondrial DNA,Molecular genetics and metabolism reports · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Roles of Mitochondrial DNA Damage in Kidney Diseases: A New Biomarker.International journal of molecular sciences · 2022
    Review
  17. Autosomal dominant tubulointerstitial kidney disease: A review.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Thomas M ConnorOxford Kidney Unit, Churchill Hospital, Oxford, United Kingdom.ORCID 0000-0002-5896-7084
Simon HoerCambridge Institute for Medical Research, University of Cambridge, United Kingdom.ORCID 0000-0002-6071-967X
Andrew MallettKidney Health Service, Royal Brisbane and Women's Hospital, School of Medicine, The University of Queensland, Australia.
Daniel P GaleUCL Centre for Nephrology, Royal Free Hospital, London, United Kingdom.ORCID 0000-0002-9170-1579
Aurora Gomez-DuranMRC-Mitochondrial Biology Unit, University of Cambridge, United Kingdom.ORCID 0000-0002-5895-6860
Viktor PosseInstitute of Biomedicine, University of Gothenburg, Sweden.
Robin AntrobusCambridge Institute for Medical Research, University of Cambridge, United Kingdom.ORCID 0000-0001-8608-4011
Pablo MorenoCambridge Institute for Medical Research, University of Cambridge, United Kingdom.
Marco SciacovelliMRC Cancer Unit, University of Cambridge, United Kingdom.
Christian FrezzaMRC Cancer Unit, University of Cambridge, United Kingdom.ORCID 0000-0002-3293-7397
Jennifer DuffInstitute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne, United Kingdom.
Neil S SheerinInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0002-3743-2371
John A SayerInstitute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0003-1881-3782
Margaret AshcroftDepartment of Medicine, University of Cambridge, United Kingdom.ORCID 0000-0002-0066-3707
Michael S WiesenerDepartment of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Gavin HudsonInstitute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne, United Kingdom.
Claes M GustafssonInstitute of Biomedicine, University of Gothenburg, Sweden.
Patrick F ChinneryMRC-Mitochondrial Biology Unit, University of Cambridge, United Kingdom.
Patrick H MaxwellSchool of Clinical Medicine, Cambridge University, Cambridge, United Kingdom.
University of Cambridge · GBCentre for Life · GBUniversity of Gothenburg · SEChurchill Hospital · GBFriedrich-Alexander-Universität Erlangen-Nürnberg · DENewcastle University · GBThe Royal Free Hospital · GBThe University of Queensland · AU

Funding

Medical Research Council G0701320Medical Research Council G0802266Medical Research Council G1002528Medical Research Council MC_UP_1501/2Medical Research Council MC_UU_12022/6Medical Research Council MR/K002201/1Medical Research Council MR/K002201/2Wellcome Trust 100140Wellcome Trust 101876/Z/13/ZWellcome Trust 19710
6 · The paper itself

Abstract

Tubulointerstitial kidney disease is an important cause of progressive renal failure whose aetiology is incompletely understood. We analysed a large pedigree with maternally inherited tubulointerstitial kidney disease and identified a homoplasmic substitution in the control region of the mitochondrial genome (m.547A>T). While mutations in mtDNA coding sequence are a well recognised cause of disease affecting multiple organs, mutations in the control region have never been shown to cause disease. Strikingly, our patients did not have classical features of mitochondrial disease. Patient fibroblasts showed reduced levels of mitochondrial tRNAPhe, tRNALeu1 and reduced mitochondrial protein translation and respiration. Mitochondrial transfer demonstrated mitochondrial transmission of the defect and in vitro assays showed reduced activity of the heavy strand promoter. We also identified further kindreds with the same phenotype carrying a homoplasmic mutation in mitochondrial tRNAPhe (m.616T>C). Thus mutations in mitochondrial DNA can cause maternally inherited renal disease, likely mediated through reduced function of mitochondrial tRNAPhe.

Indexed as

MutationAcetylglucosaminidaseBiopsyDNA, MitochondrialFemaleFibroblastsGenetic LinkageHumansKidney DiseasesKidney TubulesLeucineMaleMitochondriaOxygen ConsumptionPedigreePhenotypeAcetylglucosaminidaseDNA, MitochondrialLeucinePhenylalanineRNA, Transfer

Identifiers

PMID28267784
PMCPMC5360345
OpenAlexW2593241914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.